ERBIN and cancer: Genetic manipulations of ERBIN expression were complemented by pharmacological manipulation of TGFBR and EGFR, leading to the conclusion that TGFBR and EGFR signaling pathways collaborate to promote EMT in breast and lung (cancer) epithelial cells.